Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

NCT ID: NCT05741593

Last Updated: 2024-11-18

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 30 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-04-01
• Study Completion Date: 2026-04-01

Brief Summary

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

Detailed Description

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death.

In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction.

However, the effectiveness of these strategies is optimal if and only if patients adhere to them.

In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.

Conditions

Stroke

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: PROSPECTIVE

Study Groups

Patients having had a stroke

elderly patients previously treated with an antithrombotic and admitted to hospital for an ischemic stroke

Analysis of the verbatim from the transcription of the recorded interviews.

Intervention Type: OTHER

recorded semi-structured interviews between the patients and the pharmacist

Interventions

Analysis of the verbatim from the transcription of the recorded interviews.

recorded semi-structured interviews between the patients and the pharmacist

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients aged 65 and over
• Patients hospitalized for an ischemic stroke or a recurrence of ischemic stroke, already being treated with an antithrombotic treatment (antiplatelet agent or anticoagulant ) prior to the stroke
• Patients living at home and with a plan to return home.
• Patients who did not object to the study and who gave their consent for the recording of the interview

Exclusion Criteria

• Patients with cognitive disorders or stroke sequelae that do not allow a semi-directive interview to be carried out (at medical discretion).
• Non-French speaking patients

• Minimum Eligible Age: 65 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hospices Civils de Lyon

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

institute of aging - Hôpital des Charpennes

Villeurbanne, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Teddy Novais, PharmD, PhD

Role: CONTACT

teddy.novais@chu-lyon.fr

+33472432155

Facility Contacts

Teddy NOVAIS, PharmD, PhD

Role: primary

Other Identifiers

2023-A00181-44

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL22_1074

Identifier Type: -

Identifier Source: org_study_id